Orforglipron hemicalcium hydrate (LY3502970 hemicalcium hydrate, GLP-1 receptor agonist 1 hemicalcium hydrate) represents the hemicalcium hydrate form of the calcium salt of Orforglipron, an orally active agonist targeting the Glucagon-like peptide-1 receptor (GLP-1R). This compound has demonstrated efficacy in mitigating type 2 diabetes [1].
Molecular Weight:
921.02
CAS Number:
[3008544-96-2]
Formula:
C48H48F2N10O5.1/2Ca.H2O
Target:
Glucagon Receptor
T87071
* VAT and and shipping costs not included. Errors and price changes excepted